Your browser doesn't support javascript.
loading
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Blauwendraat, Cornelis; Reed, Xylena; Krohn, Lynne; Heilbron, Karl; Bandres-Ciga, Sara; Tan, Manuela; Gibbs, J Raphael; Hernandez, Dena G; Kumaran, Ravindran; Langston, Rebekah; Bonet-Ponce, Luis; Alcalay, Roy N; Hassin-Baer, Sharon; Greenbaum, Lior; Iwaki, Hirotaka; Leonard, Hampton L; Grenn, Francis P; Ruskey, Jennifer A; Sabir, Marya; Ahmed, Sarah; Makarious, Mary B; Pihlstrøm, Lasse; Toft, Mathias; van Hilten, Jacobus J; Marinus, Johan; Schulte, Claudia; Brockmann, Kathrin; Sharma, Manu; Siitonen, Ari; Majamaa, Kari; Eerola-Rautio, Johanna; Tienari, Pentti J; Pantelyat, Alexander; Hillis, Argye E; Dawson, Ted M; Rosenthal, Liana S; Albert, Marilyn S; Resnick, Susan M; Ferrucci, Luigi; Morris, Christopher M; Pletnikova, Olga; Troncoso, Juan; Grosset, Donald; Lesage, Suzanne; Corvol, Jean-Christophe; Brice, Alexis; Noyce, Alastair J; Masliah, Eliezer; Wood, Nick; Hardy, John.
Afiliação
  • Blauwendraat C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Reed X; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Krohn L; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Heilbron K; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Bandres-Ciga S; 23andMe, Inc., Mountain View, CA, USA.
  • Tan M; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Gibbs JR; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
  • Hernandez DG; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Kumaran R; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Langston R; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Bonet-Ponce L; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Alcalay RN; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Hassin-Baer S; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Greenbaum L; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.
  • Iwaki H; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Leonard HL; Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel.
  • Grenn FP; Movement Disorders Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Ruskey JA; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.
  • Sabir M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ahmed S; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.
  • Makarious MB; The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel.
  • Pihlstrøm L; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Toft M; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • van Hilten JJ; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Marinus J; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Schulte C; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Brockmann K; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
  • Sharma M; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
  • Siitonen A; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
  • Majamaa K; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Eerola-Rautio J; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Tienari PJ; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • Pantelyat A; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Hillis AE; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
  • Dawson TM; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Rosenthal LS; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
  • Albert MS; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tubingen, Germany.
  • Resnick SM; Institute of Clinical Medicine, Department of Neurology, University of Oulu, Oulu, Finland.
  • Ferrucci L; Department of Neurology and Medical Research Center, Oulu University Hospital, Oulu, Finland.
  • Morris CM; Institute of Clinical Medicine, Department of Neurology, University of Oulu, Oulu, Finland.
  • Pletnikova O; Department of Neurology and Medical Research Center, Oulu University Hospital, Oulu, Finland.
  • Troncoso J; Department of Neurology, Helsinki University Hospital, and Molecular Neurology, Research Programs Unit, Biomedicum, University of Helsinki, Helsinki, Finland.
  • Grosset D; Department of Neurology, Helsinki University Hospital, and Molecular Neurology, Research Programs Unit, Biomedicum, University of Helsinki, Helsinki, Finland.
  • Corvol JC; Neuroregeneration and Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University Medical Center, Baltimore, MD, USA.
  • Brice A; Neuroregeneration and Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University Medical Center, Baltimore, MD, USA.
  • Noyce AJ; Neuroregeneration and Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University Medical Center, Baltimore, MD, USA.
  • Masliah E; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA.
  • Wood N; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA.
  • Hardy J; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA.
Brain ; 143(1): 234-248, 2020 01 01.
Article em En | MEDLINE | ID: mdl-31755958
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Catepsina B / Penetrância / Doença por Corpos de Lewy / Alfa-Sinucleína / Glucosilceramidase Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Brain Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Catepsina B / Penetrância / Doença por Corpos de Lewy / Alfa-Sinucleína / Glucosilceramidase Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Brain Ano de publicação: 2020 Tipo de documento: Article